Yifeng Pharmacy Chain Co Ltd
SSE:603939
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
22.62
29.06
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Yifeng Pharmacy Chain Co Ltd
Free Cash Flow
Yifeng Pharmacy Chain Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Free Cash Flow
ÂĄ2.7B
|
CAGR 3-Years
9%
|
CAGR 5-Years
28%
|
CAGR 10-Years
44%
|
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Free Cash Flow
ÂĄ3.9B
|
CAGR 3-Years
46%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
LBX Pharmacy Chain JSC
SSE:603883
|
Free Cash Flow
ÂĄ2.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
22%
|
CAGR 10-Years
40%
|
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Free Cash Flow
ÂĄ315.8m
|
CAGR 3-Years
46%
|
CAGR 5-Years
111%
|
CAGR 10-Years
N/A
|
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Free Cash Flow
ÂĄ1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
37%
|
|
|
A
|
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
|
Free Cash Flow
ÂĄ410.9m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
Glance View
Yifeng Pharmacy Chain Co., Ltd. has carved a significant niche in China's burgeoning retail pharmacy sector. Founded in 2001, Yifeng has steadily expanded its footprint by blending traditional pharmaceutical offerings with modern retail conveniences. The company primarily operates through a well-integrated chain of drugstores strategically located throughout China's cities and towns. These stores offer a vast array of products, from prescription drugs and over-the-counter medications to health supplements and personal care products. This diversified product portfolio caters to the varying needs of its customers, ensuring a steady footfall and consistent revenue streams. Over the years, Yifeng has also invested in its supply chain management, enabling the efficient stocking of popular products and maintaining competitive pricing strategies. In addition to its physical stores, Yifeng has embraced technology with its online platform, adapting to the country's digital shift and changing consumer behaviors. This dual-channel approach enhances its reach and drives sales, complementing its in-store experience with e-commerce conveniences. By leveraging data analytics, Yifeng personalizes marketing campaigns, enhancing customer engagement and fostering loyalty. Its revenue predominantly comes from product sales, but the company is also exploring value-added services such as health consultations and wellness programs. This forward-thinking strategy not only distinguishes Yifeng from competitors but also positions it to capture a larger share of China's healthcare spending, as consumers increasingly prioritize health and wellness.
See Also
What is Yifeng Pharmacy Chain Co Ltd's Free Cash Flow?
Free Cash Flow
2.7B
CNY
Based on the financial report for Sep 30, 2025, Yifeng Pharmacy Chain Co Ltd's Free Cash Flow amounts to 2.7B CNY.
What is Yifeng Pharmacy Chain Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
44%
Over the last year, the Free Cash Flow growth was -38%. The average annual Free Cash Flow growth rates for Yifeng Pharmacy Chain Co Ltd have been 9% over the past three years , 28% over the past five years , and 44% over the past ten years .